The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Freyman Thomas C since year 2005.
The trader's CIK number is 1239126.
At the time of this reporting, Freyman Thomas C is the Executive Vice President of Abbott Laboratories .
(stock ticker symbol ABT).
See this page for all insider trading activities at Abbott Laboratories .
Stock purchases, sales, and option exercises reported by insider Freyman Thomas C since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-07-21
ABT
Abbott Laboratories
Option Exercise
27,848
53.19
1,481,235
2008-02-05
ABT
Abbott Laboratories
Option Exercise
2,012
54.62
109,895
2007-12-11
ABT
Abbott Laboratories
Option Exercise
41,057
46.78
1,920,843
2007-11-30
ABT
Abbott Laboratories
Option Exercise
64,784
45.45
2,944,355
2007-11-13
ABT
Abbott Laboratories
Option Exercise
29,245
43.73
1,278,883
2007-08-08
ABT
Abbott Laboratories
Option Exercise
19,507
41.03
800,405
2007-08-09
ABT
Abbott Laboratories
Option Exercise
24,839
46.92
1,165,435
2007-03-27
ABT
Abbott Laboratories
Option Exercise
41,621
45.45
1,891,624
2007-03-01
ABT
Abbott Laboratories
Option Exercise
2,292
43.61
99,954
2007-01-31
ABT
Abbott Laboratories
Option Exercise
31,920
42.50
1,356,529
2007-01-29
ABT
Abbott Laboratories
Option Exercise
94,830
41.25
3,911,535
2007-01-29
ABT
Abbott Laboratories
Sale
1,845
52.57
96,991
2007-01-03
ABT
Abbott Laboratories
Option Exercise
17,828
46.92
836,482
2007-01-03
ABT
Abbott Laboratories
Sale
66
49.04
3,236
2006-07-25
ABT
Abbott Laboratories
Option Exercise
6,428
42.20
271,242
2006-02-15
ABT
Abbott Laboratories
Option Exercise
35,468
33.23
1,178,651
2006-02-15
ABT
Abbott Laboratories
Sale
780
43.85
34,203
2006-01-30
ABT
Abbott Laboratories
Option Exercise
23,224
41.97
974,734
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Freyman Thomas C
(Executive Vice President of Abbott Laboratories at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
